
The Company is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease.
The best Bull and Bear pitches based on recency and number of recommendations.
I spoke with a few doctors and they pointed out that the ultimate users and buyers of this equipment have a disincentive to use it because they make more money installing the defibs and therefore don't want to find out what patients will not benefit… More
Read the most recent pitches from players about CAMH.
Recs
Good product.
Numbers: -.16 this year, projected +.13 next year
PE from -28.26 to +33.69.
marketwatch
Their site: Increase in revenue from first quarter 2006 to first quarter 2007: 83%
Recs
This technology will become the standard for determining whether defibs are needed or not. Major clinical trials all support this. Another larege clinical trial is due in Nov, 2007. Insurance coverage already in place and more to come. Recent marketing colaboration with STJ is going to propel sales and adoption. NASDAQ listing will also add to PPS appreciation. CAMH will explode over the 2 years.
Recs
MTWA test now mandatory for Medicare and half of US insured prior to implant of an ICD.
New Sales and Marketing relationship with St. Jude (STJ). 2000 experienced and connected sales professionals will soon be selling the product.
FDA Approved. Patent Holder with mo Competition.
$120M+ Revenue target with 50-65% Margin = $25+ stock over next 2 years.
Find the members with the highest scoring picks in CAMH.
donyao1 (99.81) Score: +344.39
The Score Leader is the player with the highest score across all their picks in CAMH.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
donyao1 | 99.81 | 1/4/2007 |
![]() |
3Y | $2.72 | -99.45% | +244.94% | +344.39 | 0 Comment | |
SteadySaber | 84.09 | 1/3/2007 |
![]() |
5Y | $2.77 | -99.46% | +243.38% | +342.85 | 10 Comments | |
smoaky | 91.97 | 3/28/2007 |
![]() |
5Y | $3.11 | -99.52% | +243.17% | +342.69 | 0 Comment | |
cnwarner | 21.26 | 1/31/2007 |
![]() |
5Y | $2.65 | -99.44% | +242.23% | +341.67 | 0 Comment | |
BigNORM9672 | 53.18 | 1/30/2007 |
![]() |
5Y | $2.60 | -99.43% | +242.20% | +341.63 | 0 Comment | |
gitau4ever | 53.86 | 3/22/2007 |
![]() |
NS | $3.22 | -99.54% | +239.45% | +338.99 | 1 Comment | |
plaidone | 99.25 | 2/1/2007 |
![]() |
1Y | $2.58 | -99.42% | +238.77% | +338.19 | 1 Comment | |
in7rigue96 | 87.17 | 2/7/2007 |
![]() |
3M | $2.31 | -99.35% | +236.68% | +336.04 | 0 Comment | |
AlpacaInvestor | 95.66 | 2/22/2007 |
![]() |
5Y | $2.41 | -99.38% | +235.57% | +334.96 | 0 Comment | |
jayahir | < 20 | 11/6/2007 |
![]() |
3W | $1.61 | -99.07% | +220.91% | +319.99 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.